Live Breaking News & Updates on மைக்கேல் கில்சன் கானக்கோர்ட் உண்மையானது இன்க்

Stay updated with breaking news from மைக்கேல் கில்சன் கானக்கோர்ட் உண்மையானது இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ChemoCentryx Inc (CCXI) Q1 2021 Earnings Call Transcript

ChemoCentryx Inc (CCXI) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
ChemoCentryx Inc (NASDAQ: CCXI)
Operator
Good day and thank you for standing by. Welcome to the ChemoCentryx First Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today s conference is being recorded. [Operator Instructions]
I would now like to hand the conference over to Lee Roth of Burns McClellan. Please go ahead, sir.SPONSORED:
10 stocks we like better than ChemoCentryx ....

United States , Vifor Pharma , Thomas Schall , Anupam Rama Jpmorgan , Anupam Rama , Raymond James , Edward Tenthoff Piper Sandler , Glen Massie , Michelle Gilson , Timur Ivannikov Raymond James , Hidradenitis Suppurativa , Steve Seedhouse , Dburns Mcclellan , David Jayne , Susan Kanaya , Yanan Zhu , Red White , Thomasj Schall , Susanm Kanaya , Piper Sandler , Josephp Schwartz , Timur Ivannikov , Hidradenitis Suppurativa Hurley , Ted Tenthoff , Lee Roth , Joe Schwartz ,

Eloxx Pharmaceuticals, Inc. (ELOX) Q4 2020 Earnings Call Transcript

Eloxx Pharmaceuticals, Inc. (ELOX) Q4 2020 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX)
Popular Searches
Operator
Good afternoon everyone and welcome to the Eloxx Pharmaceuticals Fourth Quarter and Full Year 2020 earnings webcast and conference call. Today s call is being recorded.
At this time, I would like to turn the call over to Barbara Ryan, Eloxx Investor Relations. Please begin.
This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company s SEC filings. Please see ....

United States , Benjamin Freedman , Edward Tenthoff Piper Sandler , Stepheng Macdonald , Piper Sandler , Greg Williams , Michelle Gilson , Steve Macdonald , Neil Belloff , Ted Tenthoff , Barbara Ryan , Tom Haverty , Matt Goddeeris , Eitan Kerem , Matthew Goddeeris , Steven Mcdonald , University Of Maryland , Eloxx Pharmaceuticals , Cystic Fibrosis Foundation , Michelle Gilson Canaccord Genuity Inc , Eloxx Pharmaceuticals Inc , Hubrecht Organoid Technology , University Of Washington , Clinical Pharmacology In Drug Development , Journal Of Experimental Eye Research , Professor Of The Division Nephrology ,